|
⚲
|
| Keyboard |
| California Capital Equity LLC
✚
|
|
|---|---|
| CIK # | 0001517764 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001517764] | |
| 4 | [0001517764] | |
| SC 13D | [0001517764] | |
| SC 13G | [0001517764] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| California Capital Equity LLC | NantHealth Inc | [2017-02-13] |
| California Capital Equity LLC | Benitec Biopharma Ltd/ADR | [2016-11-01] |
| California Capital Equity LLC | Tribune Publishing Co | [2016-06-08] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ImmunityBio Inc IBRX
Restricted Stock Units · derivative
|
2026-02-22 | Option exercise | 114,329 | $0.00 | |
|
ImmunityBio Inc IBRX
Common Stock
|
2026-02-22 | Tax withheld | 58,170 | $8.70 | 506,079 |
|
ImmunityBio Inc IBRX
Common Stock
|
2026-02-22 | Option exercise | 114,329 | $0.00 | |
|
ImmunityBio Inc IBRX
Common Stock
|
2026-02-10 | Option exercise | 274,122 | $0.00 | |
|
ImmunityBio Inc IBRX
Restricted Stock Units · derivative
|
2026-02-10 | Option exercise | 274,122 | $0.00 | |
|
ImmunityBio Inc IBRX
Common Stock
|
2026-02-10 | Tax withheld | 118,560 | $6.93 | 821,621 |
|
ImmunityBio Inc IBRX
Restricted Stock Units · derivative
|
2025-02-22 | Option exercise | 114,329 | $0.00 | |
|
ImmunityBio Inc IBRX
Common Stock
|
2025-02-22 | Option exercise | 114,329 | $0.00 | |
|
ImmunityBio Inc IBRX
Common Stock
|
2025-02-22 | Tax withheld | 42,071 | $3.42 | 143,883 |
|
ImmunityBio Inc IBRX
Common Stock
|
2024-12-10 | Conversion | 103,710,088 | $1.94 | 201,197,571 |
|
ImmunityBio Inc IBRX
Amended and Restated Promissory Note · derivative
|
2024-12-10 | Other | $0.00 | ||
|
ImmunityBio Inc IBRX
Second Amended and Restated Convertible Promissory Note · derivative
|
2024-12-10 | Other | $505,000,000.00 | ||
|
ImmunityBio Inc IBRX
Convertible Promissory Note · derivative
|
2024-12-10 | Conversion | $0.00 | ||
|
ImmunityBio Inc IBRX
Convertible Promissory Note · derivative
|
2024-12-10 | Conversion | $0.00 | ||
|
ImmunityBio Inc IBRX
Common Stock
|
2024-12-10 | Conversion | 13,475,172 | $2.28 | 30,723,392 |
|
ImmunityBio Inc IBRX
Common Stock
|
2023-09-11 | Other | 47,557,934 | $1.29 | 61,349,735 |
|
ImmunityBio Inc IBRX
Convertible Promissory Note · derivative
|
2023-09-11 | Buy | $200,000,000.00 | ||
|
ImmunityBio Inc IBRX
Amended and Restated Convertible Promissory Note · derivative
|
2023-09-11 | Other | $0.00 | ||
|
ImmunityBio Inc IBRX
Amended and Restated Convertible Promissory Note · derivative
|
2023-09-11 | Other | $0.00 | ||
|
ImmunityBio Inc IBRX
Second Amended and Restated Convertible Promissory Note · derivative
|
2023-09-11 | Other | $0.00 | ||
| showing 20 of 56 most recent transactions | |||||